NGF and Parkinson disease: However, later studies using the intraventricular infusion of NGF in AD patients concluded that the “negative side effects appear to outweigh the positive effects” (Jönhagen et al., 1998), at least for the intraventricular route of administration, and the clinical trials with NGF in PD patients were not conducted.